CA2634144C - Agent pathogene inedit de poisson - Google Patents

Agent pathogene inedit de poisson Download PDF

Info

Publication number
CA2634144C
CA2634144C CA2634144A CA2634144A CA2634144C CA 2634144 C CA2634144 C CA 2634144C CA 2634144 A CA2634144 A CA 2634144A CA 2634144 A CA2634144 A CA 2634144A CA 2634144 C CA2634144 C CA 2634144C
Authority
CA
Canada
Prior art keywords
virus
fish
cms
vaccine
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2634144A
Other languages
English (en)
Other versions
CA2634144A1 (fr
Inventor
Svein Alexandersen
Trygve Meum Eliassen
Inge Tom Solbakk
Marit Rode
Marianne Froystad-Saugen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaq AS
Original Assignee
Pharmaq AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaq AS filed Critical Pharmaq AS
Publication of CA2634144A1 publication Critical patent/CA2634144A1/fr
Application granted granted Critical
Publication of CA2634144C publication Critical patent/CA2634144C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/06—Inactivation or attenuation by chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention porte sur un virus de poisson qui, lorsquil est injecté dans un poisson, a la capacité dinduire les symptômes et la maladie du syndrome de cardiomyopathie (CMS). De plus, un vaccin est décrit comprenant un virus selon linvention ou un composant ou une partie dudit virus. Linvention a également trait à un procédé permettant disoler ou de produire le virus et dutiliser ce dernier pour la gestion des maladies chez les poissons.
CA2634144A 2007-06-28 2008-06-27 Agent pathogene inedit de poisson Active CA2634144C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200700941 2007-06-28
DKPA200700941 2007-06-28

Publications (2)

Publication Number Publication Date
CA2634144A1 CA2634144A1 (fr) 2008-12-28
CA2634144C true CA2634144C (fr) 2018-01-02

Family

ID=38472894

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2634144A Active CA2634144C (fr) 2007-06-28 2008-06-27 Agent pathogene inedit de poisson

Country Status (4)

Country Link
CA (1) CA2634144C (fr)
CL (1) CL2008001910A1 (fr)
GB (1) GB2452363B (fr)
NO (1) NO346433B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2560985B1 (fr) 2010-04-21 2016-06-29 Pharmaq AS Séquences d'acide nucléique d'un virus de poisson et leur utilisation
WO2012066481A1 (fr) * 2010-11-15 2012-05-24 Pharmaq As Nouvel agent étiologique
NO347765B1 (no) * 2012-11-01 2024-03-18 Ewos Innovation As Fôrsammensetning for fisk
CN109358194A (zh) * 2018-09-29 2019-02-19 中国海洋大学 凡纳滨对虾高血糖激素间接竞争酶联免疫检测方法
CN113122510A (zh) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法
CN119372372A (zh) * 2023-12-29 2025-01-28 广东大百汇海洋科技集团有限公司 一种石斑鱼养殖水源病原鉴定引物组、鉴定方法、试剂盒和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2429711B (en) * 2004-06-11 2008-05-21 Pharmaq As Heart and skeletal muscle inflammation (HSMI) virus

Also Published As

Publication number Publication date
CL2008001910A1 (es) 2009-08-07
NO20082869L (no) 2008-12-29
GB2452363A (en) 2009-03-04
NO346433B1 (no) 2022-08-08
GB2452363A8 (en) 2009-03-18
CA2634144A1 (fr) 2008-12-28
GB0811812D0 (en) 2008-07-30
GB2452363B (en) 2012-08-08

Similar Documents

Publication Publication Date Title
Pepin et al. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention
Howatson Vesicular stomatitis and related viruses
Essbauer et al. Viruses of lower vertebrates
EP2271663B1 (fr) Nouvel astrovirus aviaire
GB2452363A (en) Fish virus which causes Cardiomyopathy Syndrome
GB2559193A (en) Virus-like particle
CA2796178A1 (fr) Sequences d'acide nucleique du virus du syndrome de cardiomyopathie chez les poissons et son utilisation
CN109207436B (zh) 一株i群4型禽腺病毒毒株及其应用
Biacchesi et al. Rainbow trout (Oncorhynchus mykiss) muscle satellite cells are targets of salmonid alphavirus infection
JPH08188515A (ja) 組織培養物において効能のあるトキソプラズマ ゴンデイ ブラデイゾイトワクチンの生産
CA2922621C (fr) Methode de propagation de piscine orthoreovirus
CA2656032C (fr) Procede de culture de bacteries du genrepiscirickettsia
CN112063596A (zh) 鸽副黏病毒1型ppmv-1/bj-c株及其应用
CA2570050C (fr) Virus (hsmi) d'inflammation musculaire squelettique et cardiaque
US20250312431A1 (en) Vaccines against moritella viscosa
KR102365039B1 (ko) 부유세포 배양에 적응된 A/ASIA/Sea-97 유전형 구제역 바이러스 백신주 및 이의 제조방법
CN104031888B (zh) 鸡新城疫病毒弱毒株、灭活疫苗及其应用
ZA200402352B (en) Chicken anemia virus vaccine from cell line.
Saleh et al. In vitro growth of the microsporidian Heterosporis saurida in the eel kidney EK-1 cell line
KR101104911B1 (ko) 비병원성 전염성낭병 바이러스 및 이의 백신으로서의 용도
JPS62275680A (ja) 家禽の伝染性気管支炎ウイルス株
Hassan Molecular, Pathogenesis and Immunological Studies of the Canadian Delmarva (DMV/1639) Infectious Bronchitis Virus (IBV) Variant
Kanchanakhan Field and Labortory Studies on Rhabdoviruses Associated with Epizootic Ulcerative Syndrome (EUS) of Fishes
KR20250031222A (ko) 불활화 전입자 인플루엔자 백신의 발열 활성 저감 방법
EP4077355A1 (fr) Virus isa réassorti

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130620

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250509

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250509